← All trials
NCT05007587
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2021
- Primary completion
- Jun 30, 2022
- Completion date
- Jun 30, 2023
- First posted
- Aug 16, 2021
- Last posted
- Aug 16, 2021
- Enrollment
- 60
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Chinese Academy of Medical SciencesLead sponsor
- Zhejiang UniversityCollaborator
- Wenzhou Medical UniversityCollaborator
- Jinhua Central HospitalCollaborator
- Chinese Academy of Medical SciencesStudy chair
- Shaoxing People's HospitalCollaborator
- Wenzhou Medical UniversityCollaborator
- Wenzhou Medical UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.